IPO Club

IPO Club is a venture investment platform with a thesis focused on late-stage and pre-IPO companies, deploying capital into companies on a clear path to public markets within roughly 12 to 36 months. The firm operates as a syndicate or fund vehicle with limited public information about fund size, partner team, or detailed thesis. Plausible check sizes are $1M to $10M into late-stage rounds, often participating alongside larger crossover investors. Healthcare exposure is partial and opportunistic rather than thesis-driven, with selective late-stage healthcare bets where IPO timing and public market readiness are clear. AI focus is welcome but not a primary thesis. Founders best suited are CFOs and CEOs of late-stage healthcare companies with $50M-plus revenue, audited financials, public-company-ready governance, and a clear IPO timeline, who are looking to add a small late-stage participant to their crossover round. Founders who do not fit include any company earlier than late Series C or D, pre-revenue biotech, and any team that is not actively preparing for public market listing. The entry path is warm introduction through an investment banker covering healthcare equity capital markets, a crossover investor like RA Capital or Casdin, or a portfolio CEO. LinkedIn outreach to a principal with clear IPO timeline articulation is a reasonable secondary option. Founders should weight IPO Club as supplemental late-stage capital rather than a primary lead, and confirm fund pacing and committed capital before progressing.